Security key
31189P102
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE)
CUSIP: 31189P102
Q1 2014 13F Holders as of 31 Mar 2014
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 122,342,805
- Total 13F shares
- 9,563,610
- Share change
- +3,149,331
- Total reported value
- $92,835,964
- Price per share
- $9.74
- Number of holders
- 21
- Value change
- +$30,694,357
- Number of buys
- 10
- Number of sells
- 8
Report period
Q1 2014
Institutions
21
Top holders
10
FATE full security history
Newer quarter: Q2 2014
Previous quarter: Q4 2013
FATE THERAPEUTICS INC SEC filings
FATE THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 31189P102
Recent filing periods:
Top shareholders of FATE - FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.98%
|
1,197,200
|
$7,518,000 | — | 31 Dec 2013 | |
| KINGDON CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.7%
|
861,802
|
$5,412,000 | — | 31 Dec 2013 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
0.57%
|
702,000
|
$4,409,000 | — | 31 Dec 2013 | |
| FARALLON CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.44%
|
544,243
|
$3,418,000 | — | 31 Dec 2013 | |
| Board of Trustees of The Leland Stanford Junior University |
13F
|
Company |
0.25%
|
303,538
|
$1,906,000 | — | 31 Dec 2013 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.17%
|
201,900
|
$1,268,000 | — | 31 Dec 2013 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
40,991
|
$257,000 | — | 31 Dec 2013 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
26,201
|
$165,000 | — | 31 Dec 2013 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.02%
|
18,526
|
$116,000 | — | 31 Dec 2013 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.02%
|
18,500
|
$115,000 | — | 31 Dec 2013 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
10,441
|
$66,000 | — | 31 Dec 2013 | |
| UBS AG |
13F
|
Company |
0%
|
1,717
|
$11,000 | — | 31 Dec 2013 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,035
|
$6,000 | — | 31 Dec 2013 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0%
|
1,000
|
$6,000 | — | 31 Dec 2013 | |
| AMERICAN INTERNATIONAL GROUP, INC. |
13F
|
Company |
0%
|
99
|
$622 | — | 31 Dec 2013 |
Institutional Holders of FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) as of Q1 2014
As of 31 Mar 2014,
FATE THERAPEUTICS INC - Common Stock, par value $0.001 per share (FATE) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,563,610 shares.
The largest 10 holders included
FMR LLC, Polaris Venture Management Co. V, L.L.C., WELLINGTON MANAGEMENT CO LLP, KINGDON CAPITAL MANAGEMENT, L.L.C., ORBIMED ADVISORS LLC, Board of Trustees of The Leland Stanford Junior University, FARALLON CAPITAL MANAGEMENT LLC, PRINCIPAL FINANCIAL GROUP INC, VANGUARD GROUP INC, and Bank of New York Mellon Corp.
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2014 vs Q4 2013 Across Filers
Q4 2013 holders
15
Q1 2014 holders
21
Holder diff
6
| Investor | Q4 2013 Shares | Q1 2014 Shares | Share Diff | Share Chg % | Q4 2013 Value $ | Q1 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.